Chondroitin sulfate plus glucosamine sulfate shows no superiority over placebo in a randomized, double-blind, placebo-controlled clinical trial in patients with knee osteoarthritis -

Chondroitin sulfate plus glucosamine sulfate shows no superiority over placebo in a randomized, double-blind, placebo-controlled clinical trial in patients with knee osteoarthritis
Information type: Randomised controlled trials
Source: Arthritis & Rheumatology
Specialities: Anaesthesia and pain | Musculo-skeletal disorders
Summary
This RCT (n=164) found that chondroitin sulfate plus glucosamine sulfate failed to demonstrate superiority over placebo in reducing pain and function impairment in patients with symptomatic knee osteoarthritis at 6 months
UKMi comment
NICE CG177: Osteoarthritis: care and management advises that glucosamine or chondroitin products should not be offered for the management of osteoarthritis
Related links: NICE CG177: Osteoarthritis: care and management: